J. Franchino-Elder

发表

Benfotiamine and Cognitive Decline in Alzheimer's Disease: Results of a Randomized Placebo-Controlled Phase IIa Clinical Trial.

Y. Stern, L. Bettendorff, N. Schupf, 2020, Journal of Alzheimer's disease : JAD.

Healthcare resource utilization and expenditures among newly-diagnosed elderly non-valvular atrial fibrillation patients initiating oral anticoagulants

R. Chowdhury, Bríain ó. Hartaigh, H. Yuce, 2019, Journal of medical economics.

Differences in Real-World Health and Economic Outcomes Among Patients with COPD Treated with Combination Tiotropium/Olodaterol Versus Triple Therapy

S. Palli, A. Buikema, M. Frazer, 2020, Journal of managed care & specialty pharmacy.

COPD_A_284678 3239..3250

A. Buikema, L. Bengtson, J. Franchino-Elder, 2020 .

Comparison of healthcare costs among patients with non‐valvular atrial fibrillation treated with warfarin who switched to a novel oral anticoagulant

Bríain ó. Hartaigh, A. Gilligan, Xue Song, 2020 .

Healthcare Resource Utilization among Non-Valvular Atrial Fibrillation Patients Who Switched from Warfarin to a Novel Oral Anti-Coagulant

Bríain ó. Hartaigh, A. Gilligan, Xue Song, 2019, Journal of Cardiology and Cardiovascular Sciences.

Treatment and persistence with oral anticoagulants among newly diagnosed patients with non-valvular atrial fibrillation: a retrospective observational study in a US commercially insured and Medicare Advantage population

V. Willey, R. Jain, H. Tan, 2018, BMJ Open.

Comparison of all-cause costs and healthcare resource use among patients with newly-diagnosed non-valvular atrial fibrillation newly treated with oral anticoagulants

David M. Smith, A. Gilligan, Xue Song, 2018, Current medical research and opinion.

Comparison of stroke- and bleed-related healthcare resource utilization and costs among patients with newly diagnosed non-valvular atrial fibrillation and newly treated with dabigatran, rivaroxaban, or warfarin

David M. Smith, A. Gilligan, Xue Song, 2018, Expert review of pharmacoeconomics & outcomes research.

Healthcare Resource Utilization, Exacerbations, and Readmissions Among Medicare Patients with Chronic Obstructive Pulmonary Disease After Long-Acting Muscarinic Antagonist Therapy Initiation with Soft Mist versus Dry Powder Inhalers

A. Buikema, L. Bengtson, D. Singer, 2020, International journal of chronic obstructive pulmonary disease.

Risk of hospitalization in a sample of COVID-19 patients with and without chronic obstructive pulmonary disease

P. Kipnis, J. Franchino-Elder, A. Shaikh, 2022, Respiratory Medicine.

Detecting schizophrenia early: Prediagnosis healthcare utilization characteristics of patients with schizophrenia may aid early detection

K. Isenberg, A. Wallace, M. Sand, 2020, Schizophrenia Research.

Low Peak Inspiratory Flow Rates are Common Among COPD Inpatients and are Associated with Increased Healthcare Resource Utilization: A Retrospective Cohort Study

B. Wells, J. Ohar, J. Franchino-Elder, 2022, International journal of chronic obstructive pulmonary disease.

Comparison of all-cause costs and healthcare resource use among patients with newly-diagnosed non-valvular atrial fibrillation newly treated with oral anticoagulants

David M. Smith, A. Gilligan, Xue Song, 2018, Current medical research and opinion.

Improved medication adherence in COPD patients using tiotropium or tiotropium olodaterol with the HealthPrize digital behavior change program.

J. Franchino-Elder, V. Anupindi, Katrina S Firlik, 2023, Expert review of pharmacoeconomics & outcomes research.